is a hedgefund/big bank TOOL to manipulate the stock price downward. If you comprehend the short selling process, its all supply/demand that manages a stock price. Notice, the 54 million have not covered to profit....It's just been a steady rise of interest over time.
Some DNDN Short Interest History:
*Short interest in dndn went from 9 million back in early 2011 to 14 million just before Gold locked *shareholders in and announced guidance withdrawal on Aug 2011.
*Interest moved to 18 million immediately afterward.
*Then climbed to 23 million in Oct 2011
*To 32 million in March 2012
*To 54 million today.
Tracking short interest over the last 24 months saw short interest rise nearly 2 million shares per month, month over month (as the stockprice declined) to where she stands today at 54 million. This prolonged bear raid is strategic, allows incentivizing 1000's of more shares to be distributed to CEO's, his new exec team (for which they received in early Jan this year) and to his newly hired employees (eg: sales), etc... ect..
We are in Year 1 again as we started anew with the planted wallstreet CEO.
All the while the stock price declined from $57 to $36 to where she stands today..
All the while institutional holdings steadily increased; especially with Vanguard accumulating 8.5M throughout 2012!
Remember, ignore any author that tells you about how "shorts will be burned" by short squeezes! rofl
You can't burn mega-wealthy mega billion dollar entities/banks because $600M-$700M (the approximate value of 54M short) is POCKET-CHANGE TO THEM!!!!!
Everything CEO's and wallstreet does is STRATEGIC and planned well in advance.
The strategic plan to drive out old time retailers over TIME, pay em off in a lawsuit settlement, but their large institutions accumulated & got the shares sold (especially during the August 3, 2011 short selling BEAR-RAID..... has worked to a TEE!
Onward DNDN goes as the next CELGENE! Tell all you know
Sentiment: Strong Buy
Johnson does not work for banks/hedgefunds per se. Does he work with his top 10 large clients, have meetings with wallstreet analysts, and is there sick negotiation tactics at hand? YES!
Changing CEO negotiators (from CEO Gold to Johnson) allowed Johnson (with wallstreets powerful influence) to begin anew and close the NJ plant to address wallstreets concern about the COGS situation versus engaging the urology market ASAP and ramping sales up to 1344 men or more per quarter ($125M+) and hitting profitability, so as to allow access of more men to Provenge, increase research into other cancers, etc, etc.
Instead, NJ was closed, internal disruption was magnified, and manufacturing capacity had to be transferred to the Georgia plant and now we're seeing delays again with regarding when restructuring to be complete. Wallstreet used this as the time to strategically short dndn over the last 24 months and continue their flush, citing their competition propaganda, etc.
SO TODAY, we're just now engaging the enormous urology market, have the necessary number of account sites acquired (900), and implementing DTC. You can't initiate a DTC campaign until you are ready and have the necessary infrastructure set across the country. You don't want to bring in the masses and don't have the capacity/apherisis centers in place to treat. That would be idiotic!
A conspiracy story or well crafted strategic plan! Given the sick negotiation tactics and pps shenanigans following the history of dndn, its strategic for sure and wallstreet is laughing all the way to the bank while retail gets screwed and patient access to Provenge gets delayed.
Tell everyone you know today that DNDN is the next Celgene!
Sentiment: Strong Buy
Once the new CFO gets his 100's of 1000's of shares at this depressed price and everyone that is in that should be in (large institutions, DNDN mgmt., and all hired employees) then and ONLY THEN the stock price begins its gradual accent via short covering. But because this post (info) is out there for everyone to see (ala: The Loncars, Adam F, wallstreet analysts, people working for DNDN,), expect actual counters to my predictions occuring as well.
Some newbie poster like me can't be right or wallstreet would be in deep doo-doo...lolz
Does wallstreet have the power to screw shareholders and find another way to get this ACI therapy technology out there to the 60,000 that need it? Yes, so ONLY INVEST WHAT YOU CAN AFFORD TO LOSE!
Since you have to hang on every word the master negotiator in what John Johnson says and he says that they have sufficient cash to reach profitability, you're looking at dndn hitting $100M sometime over the next 4 quarters or by end of Q2, 2014.
IF THE CEO DOES ANOTHER SECONDARY FOR HIS WALLSTREET FRIENDS, ITS BECAUSE MORE LARGE CLIENTS WANTED IN DNDN BEFORE THEY HIT PROFITABILITY!
Doing $100M or treating 1076 men is still pathetic given the population is 30,000 newly diagnosed with mCRPC and the 30,000 men diagnosed last year are still living throughout this year, and DNDN is still treating only 750-850 per quarter. TRULY PATHETIC, however, what is comforting that Johnson is working with big pharma (ala JnJ & MDVN/Astellas) to move men into all the NUMEROUS TRIALS THAT HAVE BEEN INITIATED OVER THE LAST 2 YEARS AND WILL BE INTIATED GOING FORWARD!
COMMENDABLE, because its about treating these dying men ASAP!
For the CEO Johnson to finally come out in the Cannacord conference and discuss the impact of clinical trials being performed by MDVN, DNDN, and JNJ all together and the impact on revenue is commendable.
Sentiment: Strong Buy